MySize Reports Second Quarter 2025 Financial Results; Narrows Losses and Positions Percentil as a Leader in Europe's Circular Fashion Economy
AIRPORT CITY, Israel , Aug. 15, 2025 /PRNewswire/ -- With the acquisition and launch of Percentil, MySize has strengthened its position in Europe's rapidly evolving circular fashion economy — a market transformation driven by new EU legislation mandating durability, repairability, recyclability, and traceability in apparel.
"We are focused on building long-term value while delivering operational progress each quarter," said Ronen Luzon, Founder and CEO of MySize. "The EU is rewriting fashion's rulebook. Percentil is designed to help brands comply with these new standards and unlock new opportunities for growth."
Q2 and H1 2025 Highlights
Revenue: $2.0 million in the three months ended June 30, 2025, up 2% year-over-year (YoY), primarily due to the addition of Percentil; $3.5 million in the six months ended June 30, 2025, down 30% YoY, attributable to a decrease in Orgad sales due to market changes.
Gross Profit: $1.1 million in the three months ended June 30, 2025, up 14% YoY; $1.5 million in the six months ended June 30, 2025, down 30% YoY
Operating Loss: $586,000 in the three months ended June 30, 2025, a 49% improvement from the corresponding period in 2024; $1.6 million in the six months ended June 30, 2025, a 25% improvement from the corresponding period in 2024
Cash Position: $4.28 million as of June 30, 2025, with $2.90 million in inventory.
Percentil Contribution: $180,000 in revenue since May acquisition, with integration milestones ahead of schedule.
Orgad Optimization: Transition to Fulfillment by Amazon (FBA) lowered logistics costs and improved delivery efficiency.
Why Percentil Changes the Game
Percentil operates in Spain and across Europe, directly in the path of the EU's Circular Economy Action Plan and Extended Producer Responsibility (EPR) for textiles. As legislation forces brands to manage the entire lifecycle of their products — including take-back, recycling, and repair — Percentil provides a ready-made platform for compliance and growth.This is not an optional trend. It is a structural shift in the fashion industry, backed by regulation and consumer demand for sustainability. Percentil's capabilities in AI-powered product matching, garment grading, and logistics integration position it as the go-to solution for brands navigating this change.
CEO Commentary
"Some companies see regulation as a hurdle. We see it as the competitive advantage," Luzon added. "In five years, we believe European fashion resale will not be a niche — it will be the infrastructure of the industry. We intend Percentil to be at the center of that infrastructure, enabling brands to comply, delight customers, and operate profitably in a circular economy."
Strategic Highlights
Three Complementary Segments – SaaS sizing solutions (MySizeID, Naiz Fit), fashion & equipment e-commerce (Orgad), and apparel resale (Percentil).
Regulatory Tailwind Alignment – Designed to meet EPR, eco-design, and Digital Product Passport requirements as they roll out across Europe.
Technology Differentiation – FirstLook Smart Mirror and Smart Catalog enhance both resale and retail experiences.
Looking Ahead
MySize is investing in long-term market capture in the European resale space, leveraging its triple-revenue model to create operational synergies and recurring cash flow. The company expects Percentil's contribution to accelerate in the second half of 2025, driven by brand partnerships and regulatory compliance demand.
About MySize, Inc.
MySize, Inc. (Nasdaq: MYSZ), an AI-powered fashion technology company operating across sizing solutions, e-commerce, and circular fashion platforms. Its portfolio includes Orgad, a fashion and equipment e-commerce business, and Percentil, a European resale platform operating at the forefront of the continent's circular fashion legislation. MySize's solutions empower retailers to increase conversion rates, boost average order value, and reduce returns, contributing to more sustainable commerce. The company's innovations include the FirstLook Smart Mirror and Smart Catalog for in-store and online personalization. Learn more at www.mysizeid.com.
We routinely post information that may be important to investors in the Investor Relations section of our website. Follow us on Facebook, LinkedIn, Instagram, and X (formerly known as Twitter).
For more information, visit www.mysizeid.com.
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to strategic and business plans, technology, relationships, objectives and expectations for its business, growth. These statements are identified by the use of the words "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results may differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company's filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
Investor ContactOren Elmaliah, CFOir@mysizeid.com
Logo - https://mma.prnewswire.com/media/689689/3320229/MySize_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/mysize-reports-second-quarter-2025-financial-results-narrows-losses-and-positions-percentil-as-a-leader-in-europes-circular-fashion-economy-302531044.html
SOURCE My Size Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
35 minutes ago
- Bloomberg
World Economic Forum Clears Schwab, Names Fink as Co-Chair
By Updated on Save The World Economic Forum has cleared Klaus Schwab of ' material wrongdoing ' after a law firm conducted a review into potential misconduct of the institution's founder. The body also said Blackrock Inc. 's Larry Fink and Roche Holding AG vice chairman Andre Hoffmann will take over the leadership of the WEF board of trustees on an interim basis as co-chairs, according to a statement late Friday. Interim chairman Peter Brabeck-Letmathe is stepping down.
Yahoo
an hour ago
- Yahoo
Report – Inter Milan & Roma Were Ready To Agree Deal For France Star Before U-Turn
Inter Milan and Roma reportedly had an agreement for midfielder Manu Kone before a u-turn by the Giallorossi. This according to Italian outlet They report that Roma owners the Friedkins were crucial to the decision to walk away from negotiations to sell the Frenchman. Yesterday, news emerged that Inter Milan are interested in Roma midfielder Manu Kone. The Frenchman has come into the Nerazzurri's sights as a reinforcement in holding midfield. Reports indicate that Inter put a bid of around €45 million on the table. However, Roma have decided to reject that offer from the Nerazzurri. They have, for all intents and purposes, taken Kone off the market this summer. Report – Inter & Roma Had Manu Kone Agreement Before U-Turn MILAN, ITALY – NOVEMBER 17: Manu Kone' of France in action during the UEFA Nations League 2024/25 League A Group A2 match between Italy and France at on November 17, 2024 in Milan, Italy. (Photo by) According to the Gazzetta dello Sport, though, Roma had initially been open to selling Kone. Inter approached the Giallorossi recently. And they received permission to start negotiating with the player. And Kone himself would have been more than willing to make the move. The 24-year-old had an informal agreement with the Nerazzurri already. However, today Roma have made something of an about face as far as Inter's interest in Kone. The Giallorossi board spent the day discussing the possibility of selling the France international internally. On the one hand, a big fee for Kone would have financed some transfer business the other way, including signings of Jadon Sancho and Leon Bailey. The Gazzetta report that even Roma coach Gian Piero Gasperini would have been willing to make the sale. However, the Gazzetta dello Sport report, Roma owner Dan Friedkin pulled the plug. After seeing what the fan reaction was and considering the importance of Kone to the team, he decided that Kone is not for sale this summer.
Yahoo
an hour ago
- Yahoo
Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst
Eli Lilly (LLY) raised prices of its GLP-1 weight-loss injectable in the UK this week, with plans to do the same in other European countries, in response to President Trump's push to normalize pricing in peer developed nations. The effort, known as Most Favored Nations pricing, has been a goal of Trump's since his first term. He has doubled down on the efforts this year, giving pharma companies 60 days to implement changes in pricing in what he deems "freeloading" nations. The US drug economy differs from European and other developed nations, which rely on the government to negotiate prices with drugmakers, resulting in lower prices globally. "While we agree that the costs for breakthrough medicines should be more fairly shared across developed countries, we must also address the underlying structural issues in the US that have contributed to high drug prices. The US system is complex and opaque," Lilly said in a statement Thursday. The stock was up 1% in trading Friday. Eli Lilly raised the price of its GLP-1, Zepbound, from about $125 to $165 and plans an additional hike next month that would almost double its price. In a note to clients Friday, Bank of America Securities research analyst Tim Anderson questioned who would actually be impacted by the raised prices. "LLY has announced it will raise GLP-1 pricing in the UK by a healthy margin (a doubling of price, but it's unclear to whom this higher price realistically applies). It expects to do something similar in other European countries (but worth appreciating: in most European markets, there aren't price agreements in place between GLP-1 manufacturers and governments, meaning these are out-of-pocket spending markets)," Anderson wrote. Ultimately, whether or not the move results in lower US prices remains a question, though Anderson believes it likely will not. "Does this mean it will actually cut the price on the GLP-1s in the US (and on other medicines)? To us, the answer is quite likely no, or at least, not in a way that creates P&L [profit and loss planning ] risk," he wrote. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
